The Australia ECG Equipment Market is expected to witness growth from $107 Mn in 2022 to $210 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-2030. The Australian government has recently increased healthcare spending, which is likely to fuel market expansion for ECG equipment. The market is segmented by product type and by the end user. Some key players in this market include Tomlin Medical, Anatomics, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom.
The Australia ECG Equipment Market size is at around $107 Mn in 2022 and is projected to reach $210 Mn in 2030, exhibiting a CAGR of 8.80% during the forecast period. In Australia, overall health expenditure is projected to total $105.8 billion in 2022–2023, or 16.8% of all government spending. 10% of Australia's GDP, or approximately $105 billion in the fiscal year 2022, is contributed by the health industry.
Acute Myocardial Infarctions (AMI), also referred to as heart attacks, are a serious health issue in Australia. Over 76,000 hospitalisations in Australia in 2020–21 were attributable to AMI, making up 5.5% of all hospitalisations. 8,093 deaths in Australia in 2021 were attributed to AMI or 5.3% of all fatalities. In Australia, arrhythmias, heart attacks, and heart failure are just a few of the various cardiac conditions that are frequently diagnosed using ECG equipment. The test is painless and non-invasive, making it a useful instrument for identifying heart issues. Monitoring the electrical activity of the heart over time is possible with ECG devices. Patients with a history of cardiac issues or those who have had heart surgery will find this to be especially helpful. ECG equipment can be used in routine heart disease screening programs, especially in high-risk groups like older individuals or people with a family history of heart issues. The efficacy of drugs for heart conditions like beta-blockers or anti-arrhythmic can be evaluated using ECG equipment.
Market Growth Drivers
The Australian government has recently increased healthcare spending, which is likely to fuel market expansion for ECG devices. This higher expenditure may result in more money being invested in ECG equipment. Strategic partnerships and collaborations with hospitals, clinics, and research institutions can help manufacturers in Australia propel development in the ECG equipment market. These collaborations can aid producers in the creation of new goods and the expansion of their market. In Australia, the market is expanding as a result of technological developments in ECG equipment, such as wireless monitoring and cloud-based data administration. These developments are increasing the accuracy and speed of diagnosis while also making it simpler and more practical to use ECG equipment.
Market Restraints
Australia's strict regulatory standards for ECG equipment can make it difficult for new manufacturers to enter the market. Regulation compliance may also raise the price of producing and marketing ECG equipment, lowering profit margins. Numerous manufacturers are vying for market share in Australia's fiercely competitive ECG equipment industry. Price pressure could result from this, which might prevent manufacturers' revenue development.
Key Players
Australia's ECG equipment laws are under the control of the Therapeutic Goods Administration. (TGA). ECG devices distributed in Australia must be dependable and secure, according to the TGA. For manufacturers to market ECG equipment in Australia, they need a conformity assessment certificate from the TGA. The equipment's compliance with all necessary safety and efficiency standards is attested to by this certificate. The Australian Register of Therapeutic Goods requires producers to register their products before they can sell them in Australia. (ARTG). In addition to supporting various forms of medical study and development, the Australian government also funds the development of medical equipment. The Medical Study Future Fund (MRFF) offers financial support for healthcare-related studies and innovation, including the creation of new medical devices.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product Type (Revenue, USD Billion):
By End User (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The market is segmented by type and by the end user.
The Australia ECG Equipment Market is studied from 2022-2030.
Tomlin Medical, Anatomics, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom are the major companies operating in Australia's ECG Equipment market.